サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1631560

女性の健康診断の市場規模、シェア、動向分析レポート：用途別、最終用途別、地域別、2025年～2030年

Women's Health Diagnostics Market Size, Share, & Trends Analysis Report By Application (Cancer, Infectious Disease, Osteoporosis), By End Use (Hospitals, Laboratory, Home Care), By Region, 2025 - 2030

出版日
ページ情報
英文 150 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
女性の健康診断の市場規模、シェア、動向分析レポート：用途別、最終用途別、地域別、2025年～2030年
出版日: 2024年12月18日
発行: Grand View Research
ページ情報: 英文 150 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

女性の健康診断市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、世界の女性の健康診断市場規模は2030年までに314億6,000万米ドルに達する見込みです。

同市場は2025年から2030年にかけてCAGR 7.29％で拡大すると予測されます。ポイントオブケア診断の採用増加、様々な慢性疾患や生活習慣病の罹患率の増加が市場成長を刺激する主要因の一つです。このほか、さまざまな啓発プログラムの導入も、予測期間中に市場に有利に働くと予測されています。例えば、2014年には欧州委員会が「包括的がんコントロールの質向上に関する欧州ガイド」の共同活動を開始しました。

女性の健康診断は、様々な団体からの資金提供の増加により、高い成長を示しています。例えば、2015年5月、Abcodia社は、卵巣がんの早期発見のためのRisk of Ovarian Cancer Algorithm（ROCA）検査を英国で発売するために、Cambridge Innovative Capital社、Scottish Equity Partners社、Albion Ventures社、UCLB社から800万米ドルの資金提供を受けました。

最終用途別に見ると、市場は病院・診断センターと家庭用に二分されます。病院・診断センターは、病院を受診する回数が多く、より確実な検出が可能であることから、市場で大きなシェアを占めています。

アジア太平洋地域の市場は、今後数年間で大きく成長する可能性が高いです。同市場の成長は、ヘルスケアへの投資が増加していること、国際的な機器メーカーが同地域での販売網の強化に注力していること、地域内で感染症から慢性疾患への疫学的な移行が進んでいることなどに起因しています。

女性の健康診断市場レポート・ハイライト

  • 政府および民間団体による投資の増加と可処分所得の増加が市場を後押ししています。
  • 2024年の市場シェアはがんが最も高いです。同分野は、早期発見検査が利用可能であることと、がんに対する政府の取り組みにより、予測期間中に注目すべき成長を記録します。
  • 出生前検査は、出生前疾患の有病率の上昇、妊産婦年齢の上昇、ヘルスケア支出の急増、高度診断検査の開発により、同期間中に最も急成長する分野と推定されます。
  • 地域別では、北米が市場を独占し、2024年には46.21％の最大収益シェアを占めました。診断センターや画像診断センターの基盤拡大、がん患者の増加、不妊検査に対する意識の高まり、ポイントオブケア検査機器の普及などにより、2030年までその優位性を維持すると予測されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 女性の健康診断の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 市場力学
    • 市場ドライバー分析
    • 市場抑制要因分析
  • 女性の健康診断分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析

第4章 女性の健康診断市場：セグメント分析、アプリケーション別、2018年～2030年（百万米ドル）

  • 定義と範囲
  • アプリケーション市場シェア分析、2024年および2030年
  • 女性の健康診断市場、用途別、2018～2030年
  • 市場規模と予測および動向分析、2018年～2030年

第5章 女性の健康診断市場：セグメント分析、最終用途別、2018年～2030年（百万米ドル）

  • 定義と範囲
  • 最終用途市場シェア分析、2024年および2030年
  • 世界の女性の健康診断市場、最終用途別、2018～2030年
  • 市場規模と予測および動向分析、2018年～2030年

第6章 女性の健康診断市場：地域推定・動向分析

  • 地域ダッシュボード
  • 市場規模、予測動向分析、2018年～2030年：
  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • ノルウェー
    • スウェーデン
    • デンマーク
  • アジア太平洋
    • 中国
    • 日本
    • インド
    • オーストラリア
    • 韓国
    • タイ
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第7章 競合情勢

  • 市場参入企業の分類
  • 主要市場参入企業による最近の動向と影響分析
  • 企業市場シェア分析、2024年
  • 主要企業プロファイル
    • F. Hoffmann-La Roche Ltd.
    • Hologic, Inc.
    • Quest Diagnostics Incorporated
    • Abbott
    • BD
    • GE Healthcare
    • Koninklijke Philips NV
    • Aspira Women's Health
    • Thermo Fisher Scientific Inc.
    • Cardinal Health, Inc.
図表

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviation
  • Table 3. North America women's health diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 4. North America women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 5. North America women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 6. U.S. women's health diagnostics, by application, 2018 - 2030 (USD Million)
  • Table 7. U.S. women's health diagnostics, by end use, 2018 - 2030 (USD Million)
  • Table 8. Canada women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 9. Canada women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 10. Mexico women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 11. Mexico women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 12. Europe women's health diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 13. Europe women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 14. Europe women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 15. UK women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 16. UK women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 17. Germany women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 18. Germany women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 19. France women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 20. France women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 21. Italy women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 22. Italy women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 23. Spain women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 24. Spain women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 25. Norway women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 26. Norway women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 27. Sweden women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 28. Sweden women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 29. Denmark women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 30. Denmark women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 31. Asia Pacific women's health diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 32. Asia Pacific women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 33. Asia Pacific women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 34. China women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 35. China women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 36. Japan women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 37. Japan women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 38. India women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 39. India women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 40. Australia women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 41. Australia women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 42. South Korea women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 43. South Korea women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 44. Thailand women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 45. Thailand women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 46. Latin America women's health diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 47. Latin America women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 48. Latin America women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 49. Brazil women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 50. Brazil women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 51. Argentina women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 52. Argentina women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 53. Colombia women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 54. Colombia women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 55. Middle East & Africa women's health diagnostics market, by country, 2018 - 2030 (USD Million)
  • Table 56. Middle East & Africa women's health diagnostics, by bag usage, 2018 - 2030 (USD Million)
  • Table 57. Middle East & Africa women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 58. South Africa women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 59. South Africa women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 60. Saudi Arabia women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 61. Saudi Arabia women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 62. UAE women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 63. UAE women's health diagnostics market, by end use, 2018 - 2030 (USD Million)
  • Table 64. Kuwait women's health diagnostics market, by application, 2018 - 2030 (USD Million)
  • Table 65. Kuwait women's health diagnostics market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Women's health diagnostics market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Information procurement
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 Market outlook (2024)
  • Fig. 10 Segment Outlook
  • Fig. 11 Strategy framework
  • Fig. 12 Penetration & growth prospect mapping
  • Fig. 13 Market driver relevance analysis (Current & future impact)
  • Fig. 14 Market restraint relevance analysis (Current & future impact)
  • Fig. 15 Porter's five forces analysis
  • Fig. 16 SWOT analysis, by factor (political & legal, economic and technological)
  • Fig. 17 Women's health diagnostics market: Application movement analysis
  • Fig. 18 Women's health diagnostics market application outlook: Key takeaways
  • Fig. 19 Cancer market, 2018 - 2030 (USD Million)
  • Fig. 20 Infectious diseases market, 2018 - 2030 (USD Million)
  • Fig. 21 Osteoporosis market, 2018 - 2030 (USD Million)
  • Fig. 22 Pregnancy & fertility market, 2018 - 2030 (USD Million)
  • Fig. 23 Prenatal market, 2018 - 2030 (USD Million)
  • Fig. 24 Women's health diagnostics market: End Use movement analysis
  • Fig. 25 Women's health diagnostics market end use outlook: Key takeaways
  • Fig. 26 Hospitals market, 2018 - 2030 (USD Million)
  • Fig. 27 Laboratory market, 2018 - 2030 (USD Million)
  • Fig. 28 Home care market, 2018 - 2030 (USD Million)
  • Fig. 29 Others market, 2018 - 2030 (USD Million)
  • Fig. 30 Regional outlook, 2019 & 2027
  • Fig. 31 Regional market place: Key takeaways
  • Fig. 32 North America, SWOT, by PEST
  • Fig. 33 Europe, SWOT, by PEST
  • Fig. 34 Asia Pacific, SWOT, by PEST
  • Fig. 35 Latin America, SWOT, by PEST
  • Fig. 36 Middle East and Africa,, SWOT, by PEST
  • Fig. 37 North America women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 38 US women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 39 Canada women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 40 Mexico women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 41 Europe women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 42 UK women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 43 Germany women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 44 France women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 45 Italy women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 46 Spain women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 47 Norway women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 48 Denmark women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 49 Sweden women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 50 Asia Pacific women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 51 Japan women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 52 China women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 53 India women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 54 Australia women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 55 South Korea women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 56 Thailand women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 57 Latin America women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 58 Brazil women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 59 Argentina women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 60 MEA women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 61 South Africa women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 62 Saudi Arabia women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 63 UAE women's health diagnostics market, 2018 - 2030 (USD Million)
  • Fig. 64 Kuwait women's health diagnostics market, 2018 - 2030 (USD Million)
目次
Product Code: GVR-2-68038-581-6

Women's Health Diagnostics Market Growth & Trends:

The global women's health diagnostics market size is expected to reach USD 31.46 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 7.29% from 2025 to 2030. Rising adoption of point-of-care diagnostics and growing incidence of various chronic and lifestyle diseases are among the key factors stimulating the growth of the market. Besides this, introducing various awareness programs is also anticipated to work in favor the market during the forecast period. For instance, in 2014, the European Commission launched joint action for European Guide on Quality Improvement in Comprehensive Cancer Control.

Women's health diagnostics is witnessing high growth due to increased funding from various organizations. For instance, in May 2015, Abcodia received funding of USD 8.0 million from Cambridge Innovative Capital, Scottish Equity Partners, Albion Ventures, and UCLB to launch Risk of Ovarian Cancer Algorithm (ROCA) test in the U.K. for early detection of ovarian cancer.

On the basis of end use, the market has been bifurcated into hospital & diagnostics centers and home. Hospitals and diagnostic centers accounted for a larger share in the market due to high number of visits to hospitals and more reliable detection.

The market in Asia Pacific is likely to witness significant growth over the coming years. The growth of the market can be attributed to increasing investments in healthcare, growing focus of international device manufacturers on strengthening their distribution networks within the region, and epidemiological shift from infectious diseases to chronic diseases within regional boundaries.

Women's Health Diagnostics Market Report Highlights:

  • Increasing investments by governments and private bodies and rising disposable income are providing a push to the market
  • Cancer accounted for the highest share in the market in 2024. The segment will register noteworthy growth during the forecast period owing to availability of early detection tests and government initiatives to tackle cancer
  • Prenatal testing is estimated to be the fastest growing segment during the same period owing to rising prevalence of prenatal diseases, increasing maternal age, surging healthcare expenditure, and development of advanced diagnostic tests
  • Geographically, North America dominated the market and accounted for the largest revenue share of 46.21% in 2024. It is anticipated to maintain its dominance through 2030, thanks to widening base of diagnostic and imaging centers, mounting cases of cancer, growing awareness about fertility testing, and spiraling adoption of point-of-care testing devices

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Application
    • 1.2.2. End Use
    • 1.2.3. Regional Scope
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Regional outlook
  • 2.4. Competitive Insights

Chapter 3. Women's Health Diagnostics Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Rising prevalence of various health conditions in women
      • 3.2.1.2. Growing women health awareness,
      • 3.2.1.3. Technological advancements in diagnostics equipment
      • 3.2.1.4. Aging women population
      • 3.2.1.5. Developing global healthcare infrastructure
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Lack of access of diagnostic solutions
      • 3.2.2.2. High cost of diagnostic solutions
  • 3.3. Women's Health Diagnostics Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Women's Health Diagnostics Market: Segment Analysis, By Application, 2018 - 2030 (USD Million)

  • 4.1. Definition and Scope
  • 4.2. Application Market Share Analysis, 2024 & 2030
  • 4.3. Women's Health Diagnostics Market, by Application, 2018 to 2030
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 4.4.1. Cancer
      • 4.4.1.1. Cancer market, 2018 - 2030 (USD Million)
    • 4.4.2. Infectious diseases
      • 4.4.2.1. Infectious diseases market, 2018 - 2030 (USD Million)
    • 4.4.3. Osteoporosis
      • 4.4.3.1. Osteoporosis market, 2018 - 2030 (USD Million)
    • 4.4.4. Pregnancy & fertility
      • 4.4.4.1. Pregnancy & fertility market, 2018 - 2030 (USD Million)
    • 4.4.5. Prenatal
      • 4.4.5.1. Prenatal market, 2018 - 2030 (USD Million)

Chapter 5. Women's Health Diagnostics Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)

  • 5.1. Definition and Scope
  • 5.2. End Use Market Share Analysis, 2024 & 2030
  • 5.3. Global Women's Health Diagnostics Market, by End Use, 2018 to 2030
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
    • 5.4.1. Hospitals
      • 5.4.1.1. Hospitals market, 2018 - 2030 (USD Million)
    • 5.4.2. Laboratory
      • 5.4.2.1. Laboratory market, 2018 - 2030 (USD Million)
    • 5.4.3. Home care
      • 5.4.3.1. Home care market, 2018 - 2030 (USD Million)
    • 5.4.4. Others
      • 5.4.4.1. Others market, 2018 - 2030 (USD Million)

Chapter 6. Women's Health Diagnostics Market: Regional Estimates & Trend Analysis

  • 6.1. Regional Dashboard
  • 6.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 6.3. North America
    • 6.3.1. U.S.
      • 6.3.1.1. Key country dynamics
      • 6.3.1.2. Regulatory framework/ reimbursement structure
      • 6.3.1.3. Competitive scenario
      • 6.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.2. Canada
      • 6.3.2.1. Key country dynamics
      • 6.3.2.2. Regulatory framework/ reimbursement structure
      • 6.3.2.3. Competitive scenario
      • 6.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.3.3. Mexico
      • 6.3.3.1. Key country dynamics
      • 6.3.3.2. Regulatory framework/ reimbursement structure
      • 6.3.3.3. Competitive scenario
      • 6.3.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.4. Europe
    • 6.4.1. UK
      • 6.4.1.1. Key country dynamics
      • 6.4.1.2. Regulatory framework/ reimbursement structure
      • 6.4.1.3. Competitive scenario
      • 6.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Germany
      • 6.4.2.1. Key country dynamics
      • 6.4.2.2. Regulatory framework/ reimbursement structure
      • 6.4.2.3. Competitive scenario
      • 6.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. France
      • 6.4.3.1. Key country dynamics
      • 6.4.3.2. Regulatory framework/ reimbursement structure
      • 6.4.3.3. Competitive scenario
      • 6.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.4. Italy
      • 6.4.4.1. Key country dynamics
      • 6.4.4.2. Regulatory framework/ reimbursement structure
      • 6.4.4.3. Competitive scenario
      • 6.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.5. Spain
      • 6.4.5.1. Key country dynamics
      • 6.4.5.2. Regulatory framework/ reimbursement structure
      • 6.4.5.3. Competitive scenario
      • 6.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.6. Norway
      • 6.4.6.1. Key country dynamics
      • 6.4.6.2. Regulatory framework/ reimbursement structure
      • 6.4.6.3. Competitive scenario
      • 6.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.7. Sweden
      • 6.4.7.1. Key country dynamics
      • 6.4.7.2. Regulatory framework/ reimbursement structure
      • 6.4.7.3. Competitive scenario
      • 6.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.8. Denmark
      • 6.4.8.1. Key country dynamics
      • 6.4.8.2. Regulatory framework/ reimbursement structure
      • 6.4.8.3. Competitive scenario
      • 6.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.5. Asia Pacific
    • 6.5.1. China
      • 6.5.1.1. Key country dynamics
      • 6.5.1.2. Regulatory framework/ reimbursement structure
      • 6.5.1.3. Competitive scenario
      • 6.5.1.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.2. Japan
      • 6.5.2.1. Key country dynamics
      • 6.5.2.2. Regulatory framework/ reimbursement structure
      • 6.5.2.3. Competitive scenario
      • 6.5.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.3. India
      • 6.5.3.1. Key country dynamics
      • 6.5.3.2. Regulatory framework/ reimbursement structure
      • 6.5.3.3. Competitive scenario
      • 6.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.4. Australia
      • 6.5.4.1. Key country dynamics
      • 6.5.4.2. Regulatory framework/ reimbursement structure
      • 6.5.4.3. Competitive scenario
      • 6.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.5. South Korea
      • 6.5.5.1. Key country dynamics
      • 6.5.5.2. Regulatory framework/ reimbursement structure
      • 6.5.5.3. Competitive scenario
      • 6.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.5.6. Thailand
      • 6.5.6.1. Key country dynamics
      • 6.5.6.2. Regulatory framework/ reimbursement structure
      • 6.5.6.3. Competitive scenario
      • 6.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 6.6. MEA
    • 6.6.1. South Africa
      • 6.6.1.1. Key country dynamics
      • 6.6.1.2. Regulatory framework/ reimbursement structure
      • 6.6.1.3. Competitive scenario
      • 6.6.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.2. Saudi Arabia
      • 6.6.2.1. Key country dynamics
      • 6.6.2.2. Regulatory framework/ reimbursement structure
      • 6.6.2.3. Competitive scenario
      • 6.6.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.3. UAE
      • 6.6.3.1. Key country dynamics
      • 6.6.3.2. Regulatory framework/ reimbursement structure
      • 6.6.3.3. Competitive scenario
      • 6.6.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.6.4. Kuwait
      • 6.6.4.1. Key country dynamics
      • 6.6.4.2. Regulatory framework/ reimbursement structure
      • 6.6.4.3. Competitive scenario
      • 6.6.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Market Participant Categorization
  • 7.2. Recent Developments & Impact Analysis by Key Market Participants
  • 7.3. Company Market Share Analysis, 2024
  • 7.4. Key Company Profiles
    • 7.4.1. F. Hoffmann-La Roche Ltd.
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Hologic, Inc.
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Quest Diagnostics Incorporated
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Abbott
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. BD
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. GE Healthcare
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. Koninklijke Philips N.V.
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. Aspira Women's Health
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Thermo Fisher Scientific Inc.
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives
    • 7.4.10. Cardinal Health, Inc.
      • 7.4.10.1. Company overview
      • 7.4.10.2. Financial performance
      • 7.4.10.3. Product benchmarking
      • 7.4.10.4. Strategic initiatives